Results 1 to 10 of about 12,392,515 (266)

Marstacimab for the Treatment of Hemophilia A or B

open access: yesBiologics: Targets and Therapy
Hemophilia A and B, caused by deficiencies of coagulation factors VIII or IX, result in impaired thrombin generation with consequent spontaneous or trauma-related bleeding, particularly hemarthroses. Although prophylactic factor replacement therapy remains the global standard of care for hemophilia, it has significant limitations, including intravenous
openaire   +4 more sources

Molecular diagnosis of hemophilia A and B. Report of five families from Costa Rica

open access: yesRevista de Biología Tropical, 2004
Hemophilia Aand B are X-chromosome linked bleeding disorders caused by deficiency of the respective coagulation factor VIII and IX. Affected individuals develop a variable phenotype of hemorrhage caused by a broad range of mutations within the Factor ...
Lizbeth Salazar-Sánchez   +8 more
doaj  

"Diagnosis of Hemophilia B Carriers, Using Taq I and Xmn I Polymorphisms of the FactorIX Gene in Iranian Individuals"

open access: yesIranian Journal of Public Health, 2003
Hemophilia B is factor IX deficiency and is inherited as X-linked recessive disorder. The subject of carrier detection in hemophilias has received new impetus in the last several years.
P Ghandil   +3 more
doaj  

Occult Hemophilia B and Plastic Surgery: Preventing Bleeding Events. [PDF]

open access: yesPlast Reconstr Surg Glob Open
Cárdenas-Camarena L   +2 more
europepmc   +1 more source

Case Report: Atypical presentations of neonatal and infantile hemophilia B. [PDF]

open access: yesFront Pediatr
Locke A   +6 more
europepmc   +1 more source

Extravascular distribution of factor IX-review of experimental and clinical evidence, and relevance for hemophilia B replacement therapy. [PDF]

open access: yesRes Pract Thromb Haemost
Hermans C   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy